Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Sep 2.
Published in final edited form as: FEBS Lett. 2013 Jul 10;587(17):2842–2850. doi: 10.1016/j.febslet.2013.07.006

A Mutational Analysis of Active Site Residues in trans-3-Chloroacrylic Acid Dehalogenase

Gerrit J Poelarends 1,||,§, Hector Serrano 1,§, Jamison P Huddleston 1, William H Johnson Jr 1, Christian P Whitman 1,*
PMCID: PMC3779635  NIHMSID: NIHMS511401  PMID: 23851010

Abstract

trans -3-Chloroacrylic acid dehalogenase (CaaD) catalyzes the hydrolytic dehalogenation of trans-3-haloacrylates to yield malonate semialdehyde by a mechanism utilizing βPro-1, αArg-8, αArg-11, and αGlu-52. These residues are implicated in a promiscuous hydratase activity where 2-oxo-3-pentynoate is processed to acetopyruvate. The roles of three nearby residues (βAsn-39, αPhe-39, and αPhe-50) are unexplored. Mutants were constructed at these positions (βN39A, αF39A, αF39T, αF50A and αF50Y) and kinetic parameters determined along with those of the αR8K and αR11K mutants. Analysis indicates that αArg-8, αArg-11, and βAsn-39 are critical for dehalogenase activity whereas αArg-11 and αPhe-50 are critical for hydratase activity. Docking studies suggest structural bases for these observations.

1. Introduction

trans-3-Chloroacrylic acid dehalogenase (CaaD) is a heterohexameric enzyme, which consists of small α-subunits (75 amino acids) and β-subunits (70 amino acids), that converts the trans-isomers of 3-haloacrylates (1 and 2, Scheme 1) to malonate semialdehyde (5), presumably through a halohydrin or enol intermediate (3 and 4, respectively) [1,2]. CaaD is part of a catabolic pathway in Pseudomonas pavonaceae 170 for trans-1,3-dichloropropene, one of the active ingredients in the agricultural nematocides Shell D-D and Telone II [1,3,4]. The enzyme belongs to the tautomerase superfamily, a group of structurally homologous proteins characterized by a conserved β–α–β structural motif and a catalytically important amino-terminal proline [5,6].

Scheme 1.

Scheme 1

In addition to the dehalogenation of the trans-3-haloacrylates, CaaD catalyzes the hydration of 2-oxo-3-pentynoate (6, Scheme 2A) and 3-chloro- and 3-bromopropiolate (7 and 8 in Scheme 2B) [7]. Upon hydration, the 3-halopropiolates are converted into potent irreversible inhibitors of CaaD (an acyl halide or a ketene). Inactivation of the enzyme results from the covalent modification of βPro-1 (9, Scheme 2B). Hydration of 6 affords acetopyruvate (10), which does not inactivate the enzyme. Although not physiologically relevant, these reactions are analogous to the hydrolytic dehalogenation of 1 and 2, and their study has provided much insight into the catalytic mechanism of CaaD [8].

Scheme 2.

Scheme 2

For example, much knowledge has been gained from the crystal structure of CaaD inactivated by 3-bromopropiolate (8 to 9, Scheme 2B) [9]. The structure identified the active site and suggested interactions that might be responsible for binding and catalysis. In the structure of the inactivated enzyme (Figure 1, PDB entry 1S0Y), βPro-1 forms a covalent bond to the C-3 of a 3-oxopropanoate moiety, which is the adduct resulting from the enzyme-catalyzed hydration of 8 (Scheme 2B). The carboxylate group interacts with αArg-8 and αArg-11, and the remaining portion of the adduct makes hydrophobic contacts with αPhe-50, αLeu-57, and βIle-37. The carboxylate group of αGlu-52 appears fixed by the amide side chain of βAsn-39. αPhe-39 and α Phe-50 contribute to the active site environment and form part of the active site wall.

Fig. 1.

Fig. 1

A close-up of one CaaD active site where the prolyl nitrogen is covalently attached to the 3-oxopropanoate moiety (PDB entry 1S0Y). The residues comprising the active site include β P1, βI37, βN39, αE52, αF39′, αL57, αF50, αR8, and αR11 (clockwise from βP1). The prime indicates that αF39′ is from an adjacent subunit. The core set of residues consists of βP1, αE52, αR8, and αR11. The residues under investigation nearby the core set are βN39, αF39′, and αF50. A putative halide binding pocket consists of βI37, αL57, αF39′, and αF50. The Figure was created with PyMol [20].

Based on this arrangement of active site residues, a working hypothesis for the mechanism of CaaD was formulated (Scheme 3). The positions of αGlu-52 and βPro-1 in the active site, coupled with the determination of a pKa value for βPro-1 of ~9.3 [10], implicated αGlu-52 as the general base catalyst that activates a water molecule for attack at C-3 of 1 (or 2) and βPro-1 as the general acid catalyst that provides a proton at C-2. Mutagenesis of these residues confirmed their importance in the mechanism: there was no detectable activity for the αE52Q mutant and greatly reduced activity for the βP1A mutant [1,9]. The two arginines (αArg-8 and αArg-11) likely interact with the C-1 carboxylate group to align the substrate and draw electron density away from C-3. Such an interaction would make C-3 partially positively charged and facilitate the Michael addition of water to generate the intermediate (3 or 4) by route A or B (Scheme 3). Replacing either residue by alanine resulted in no detectable activity [1,9].

Scheme 3.

Scheme 3

In this work, the contributions made by βAsn-39, αPhe-39, and αPhe-50 to the activities of CaaD were assessed by mutagenesis and docking studies. Accordingly, βAsn-39 was replaced with an alanine, αPhe-39 was replaced with an alanine or a threonine, and αPhe-50 was replaced with an alanine or a tyrosine. Subsequently, the kinetic parameters for each mutant-catalyzed reaction (using 1, 2, or 6), as well as the pH-rate profile of the αF50A-CaaD-catalyzed reaction (using 2), were determined and compared to those of the wild-type. In addition, the roles of α Arg-8 and αArg-11 were examined in more detail by analyzing the kinetic properties of both their alanine (with 6) and lysine mutants (with 1, 2, and 6). The results show that the interactions of αArg-8 and αArg-11, or a similar cationic group such as lysine, with substrate play an important role in both substrate binding and catalysis. The interaction between the amide side chain of βAsn-39 and the carboxylate group of αGlu-52 is critical for positioning the αGlu-52 side chain in a favorable orientation for the activation of a water molecule [11,12]. This activation of water is essential for the conversion of the 3-haloacrylates 1 and 2, but not for the conversion of the more electrophilic substrate 6. Finally, the results suggest that αPhe-50 plays a much more significant role in the CaaD reactions than αPhe-39: αPhe-50 is likely critical for maintaining the active site structural integrity and environment.

2. Material and methods

2.1. Materials

Chemicals, biochemicals, buffers, solvents, and molecular biology reagents were obtained from sources reported elsewhere [13], or as indicated below. Literature procedures were used for the synthesis of trans-3-bromoacrylic acid (2) and 2-oxo-3-pentynoate (6) [7,14]. The sources for the components of Luria-Bertani (LB) media as well as the enzymes and reagents used in the molecular biology procedures are reported elsewhere [13,15]. The Amicon concentrator and the YM10 ultrafiltration membranes were obtained from Millipore Corp. (Billerica, MA). Pre-packed PD-10 Sephadex G-25 columns were purchased from Biosciences AB (Uppsala, Sweden). Oligonucleotides for DNA amplification and sequencing were synthesized by Genosys (The Woodlands, TX). Escherichia coli strain BL21-Gold(DE3) was obtained from Agilent Technologies (Santa Clara, CA). The construction of the αR8A, αR11A, αR11K, and αF39A mutants of CaaD are described elsewhere [1,9].

2.2. General Methods

Techniques for restriction enzyme digestion, ligation, transformation, and other standard molecular biology manipulations were based on methods described elsewhere [15]. The PCR was carried out in a Perkin-Elmer DNA thermocycler Model 480 obtained from Perkin Elmer Inc. (Wellesley, MA). DNA sequencing was performed by the DNA Core Facility housed in the Institute for Cellular and Molecular Biology (ICMB) at The University of Texas at Austin. Mass spectral data was collected in the ICMB Protein and Metabolite Facility. Samples were made up as previously described [7]. HPLC was performed on a Waters (Milford, MA) 501/510 system using either a TSKgel DEAE-5PW (anion exchange) or a TSKgel Phenyl-5PW (hydrophobic interaction) column (Tosoh Bioscience, Montgomeryville, PA). Protein was analyzed by polyacrylamide gel electrophoresis (PAGE) under denaturing conditions using sodium dodecyl sulfate (SDS) on gels containing 15% polyacrylamide [16]. The gels were stained with Coomassie brilliant blue. Protein concentrations were determined using the Waddell method [17]. The native molecular masses of CaaD and the mutant enzymes were determined by gel filtration chromatography on a Superose 12 column (Pharmacia Biotech AB, Uppsala, Sweden) using the Waters 501/510 HPLC system. Kinetic data were obtained on a Hewlett Packard 8452A or an Agilent 8453 Diode Array spectrophotometer. The contents of the cuvettes were mixed using a stir/add cuvette mixer (Bel-Art Products, Pequannock, NJ). The kinetic data were fitted by nonlinear regression data analysis using the Grafit program (Erithacus, Software Ltd., Horley, U.K.) obtained from Sigma Chemical Co.

2.3. Construction of the CaaD Mutants

The five CaaD mutants were constructed using the coding sequence for CaaD in pET44T2 as the template [1]. The αR8K mutant was generated by the PCR using the primer 5′-CACGGCATATGCCGATGATCTCTTGCGACATGAAATATGGGAGAACA-3′, in which the NdeI restriction site is shown in bold and the codon introducing the mutation is underlined. This primer corresponds to the 5′ end of the wild-type coding sequence and was used in combination with the reverse primer (primer R), 5′-TTGCCCAAGCAGAGGGATCCCCTAGCT-3′, in which the BamHI site is shown in bold. The αF39T, αF50A, αF50Y, and βN39A mutants were generated by overlap extension PCR [18]. The forward primer (primer F), 5′-CACGGCATATGCCGATGATCTCTTGCGAC-3′, where the NdeI site is shown in bold, and primer R (above) were used as the external primers. The internal primers were as follows: 5′-CCCCGCGAGAACATTACCTTTGTGATTCGG-3′ and 5′-CCGAATCACAAAGGTAATGTTCTCGCGGGG-3′ for the αF39T mutant; 5′-ATTCGGGAGGGCAGCGGGATCAACGCCGTTGAGCACGGC-3′ and 5′-GTTGATCCCGCTGCCCTCCCGAAT-3′ (primer A) for the αF50A mutant; 5′-ATTCGGGAGGGCAGCGGGATCAACTACGTTGAGCACGGC-3′ and primer A for the αF50Y mutant; and 5′-TCCGACCCCAAGATCATCGCTGTGCTTCTGGTG-3′ and 5′-GATGATCTTGGGGTCGGA-3′ for the βN39A mutant. The codon introducing the mutation is underlined in each primer. The PCR reactions were carried out as described before, and the products were purified and cloned into the pET3a vector (Promega Corp., Madison, WI) for expression of the mutant genes [1]. The mutant genes were sequenced in order to verify that only the intended changes had been introduced.

2.4. Expression, Purification, and Characterization of the CaaD Mutants

Expression and purification of the CaaD mutants followed previously described procedures [1,7]. The purified enzymes were analyzed by electrospray ionization mass spectrometry (ESI-MS). The specific dehalogenase activities of the purified mutant enzymes were measured by incubating an appropriate amount of enzyme with 3 mL of 10 mM substrate (either 1 or 2) in 50 mM Tris-SO4 buffer (pH 8.2) at 22°C. Halide release was monitored colorimetrically as described before [1].

Kinetic assays were performed in 20 mM sodium phosphate buffer (pH 9.0) at 22 °C. The hydration of the trans-3-haloacrylates was monitored by following the decrease in absorbance at 224 nm, which corresponds to the hydration of 1 (ε = 4900 M−1cm−1) and 2 (ε = 9700 M−1cm−1) [7]. The hydration of 6 was monitored by following acetopyruvate (10) production at 294 nm (ε = 7000 M−1cm−1) [7]. The pH dependence of the steady-state kinetic parameters was measured in 20 mM sodium phosphate buffers, with pH values ranging from 6.0–9.1, as previously described [10].

2.5. Docking Studies

Docking studies were carried out using PyMOL with Autodock Vina using 2 and 6 [19,20]. The strategy for the identification of a specific active site to use in the docking studies is described elsewhere [12]. A CaaD active site with the 3-oxopropanoate moiety covalently bound to βPro-1 (PDB entry 1S0Y) was selected as the receptor site for docking studies. The atoms making up this adduct were removed (in silico) before the docking experiments were carried out. Docking trials were restricted to a 15Å × 15Å × 15Å box centered on the βPro-1 residue. The αR8K, αR11K, and αF50A mutants of CaaD were individually designed in silico using Pymol mutagenesis wizard [21]. The selected lysine rotomers had minimal steric clashes and placed the positively charged amino group nearest to the location observed for the guanidinium moieties of the arginines in the wild type enzyme. The side chains of αE52, αR8K and αR11K were made allowed to rotate freely in their individual docking routines.

3. Results

3.1. Expression, Purification, and Characterization of the CaaD Mutants

Five single site-directed mutants (αR8K, αF39T, βN39A, αF50A, and αF50Y) of CaaD, constructed in this work, and the four previously constructed mutants (αR8A, αR11A, αR11K, and αF39A) were overexpressed in E. coli strain BL21(DE3), and purified to >95% homogeneity (as assessed by SDS-PAGE) using previously described procedures [1,7,9]. DNA sequencing verified that only the intended mutations had been introduced into each mutant gene. The yields (in mg of homogeneous protein per liter of cell culture) of the mutants varied from 5–25 mg.

The nine purified CaaD mutants were analyzed by ESI-MS and gel filtration chromatography. Mass spectral analysis of the individual mutants showed two major peaks corresponding to the expected molecular masses of the α- and β-subunit of each mutant (Table 1). This observation indicates that each mutant has undergone posttranslational processing to remove the initiating methionine, resulting in α- and β-subunit with an N-terminal proline [22,23]. In addition, the experimentally obtained molecular masses of the purified mutant proteins confirmed the presence of only the intended amino acid substitutions. The mutant enzymes migrated during gel filtration chromatography comparably with the wild-type enzyme, suggesting that gross conformational changes are not likely present and that the characteristic heterohexameric quaternary structure of the wild-type is present in the mutant enzymes [9].

Table 1.

The Observed and Calculated Monomer Masses of Wild-type CaaD and the Active Site Mutants

Enzyme Observed mass of the α-subunita Calculated mass of the α-subunitb Observed mass of the β-subunita Calculated mass of the β-subunitb
CaaD 8,343 8,343 7,506 7,506
αR8A 8,257 8,258 7,506 7,506
αR8K 8,314 8,315 7,505 7,506
αR11A 8,257 8,258 7,506 7,506
αR11K 8,313 8,315 7,505 7,506
αF39A 8,266 8,267 7,506 7,506
αF39T 8,297 8,297 7,505 7,506
βN39A 8,343 8,343 7,463 7,463
αF50A 8,266 8,267 7,505 7,506
αF50Y 8,359 8,359 7,506 7,506
a

The masses of the two subunits of each of the purified proteins were determined by electrospray ionization mass spectrometry [7]. A sample generates two major peaks in the mass spectrum (after deconvolution) that correspond to the expected masses of the α- and β-subunits. The observed masses of the two peaks indicate that the amino-terminal proline is not blocked in either subunit by the initiating methionine [22,23].

b

The monomer masses are predicted from analysis of the translated amino acid sequences of the two genes coding for the α- and β-subunits of CaaD, but without the initiating methionines.

3.2. Specific Activities of the Mutant Enzymes

Specific activities for the nine mutant enzymes were measured using saturating concentrations of the trans-3-haloacrylates and expressed relative to the wild-type enzyme (Table 2) [1]. Changing αArg-8 to an alanine or a lysine and changing αArg-11 to an alanine (individually) essentially abolished catalytic activity of CaaD, confirming that these arginines are critical for enzymatic activity. The αR11K mutant had partially restored catalytic activity compared to the catalytically inactive αR11A mutant, suggesting that a positive charge at this position is important for activity. The αF39A, αF39T, βN39A, and αF50A mutants are also able to process both trans-3-haloacrylates, although with reduced activities (Table 2). In contrast, changing αPhe-50 to a tyrosine results in an enzyme with increased activity (~2.3-fold) for both trans-3-haloacrylates.

Table 2.

Specific Activities of Wild-type CaaD and the Active-site Mutantsa

Enzyme Relative specific activity with 1 Relative specific activity with 2
CaaD 100 100
αR8A < 0.01 < 0.01
αR8K < 0.01 < 0.01
αR11A < 0.01 < 0.01
αR11K 19 26
αF39A 20 9
αF39T 31 25
βN39A 3 5
αF50A 25 5
αF50Y 233 225
a

The specific activities were determined in 50 mM Tris-SO4 buffer (pH 8.2) at 22°C using saturating concentrations (i.e., 10 mM) of the indicated substrate [1]. Specific activity data are expressed relative to wild-type CaaD values, which are defined as 100 and are equivalent to 5080 mU/mg and 12210 mU/mg for trans-3-chloroacrylate (1) and trans-3-bromoacrylate (2), respectively, where 1 mU/mg is defined as 1 nmol of halide produced per min per mg of protein. The error associated with specific activity measurements is less than 10% of the value.

3.3 Kinetic Analysis of the Mutant Enzymes

The steady-state kinetic parameters for the hydratase activity of the nine mutants were measured using the trans-3-haloacrylates (1 and 2) (Table 3) and 2-oxo-3-pentynoate (6) (Table 4) as substrates, and compared to the kinetic parameters for the hydratase activity of wild-type CaaD. Changing αArg-8 to an alanine or a lysine results in enzymes with no measurable activity using 1 or 2. These mutants, however, are still able to process 6 to 10, although at reduced catalytic efficiencies. For the αR8A mutation, there is a ~14-fold decrease in kcat and a ~3.2-fold increase in Km. As a result, the kcat/Km is reduced ~46-fold. For the αR8K mutation, there is a ~12-fold decrease in kcat and a ~7.3-fold decrease in Km. This results in a kcat/Km that is nearly comparable to that of wild-type. Changing αArg-11 to an alanine results in an enzyme with no detectable activity using any of the three substrates. However, the αR11K CaaD is an active enzyme. Using 1, the kcat for the αR11K-catalyzed reaction is estimated to be down at least 47-fold, but an accurate Km value could not be determined. Using 2, the kcat for the αR11K-catalyzed reaction is down ~39-fold and the Km is up ~6.7-fold, resulting in a ~264-fold reduction in kcat/Km. Using 6, the kcat for the αR11K-catalyzed reaction is up ~2.4-fold and the Km is up ~15-fold, resulting in a ~6.4-fold decrease in kcat/Km.

Table 3.

Kinetic Parameters for the Hydration of 1 and 2 by CaaD and the Active Site mutantsa

enzyme substrate kcat (s−1) Km (μM) Kcat/Km (M−1 s−1)
CaaDb 1 3.8 ± 0.1 31 ± 2 1.2 × 105
2 5.1 ± 0.1 37 ± 2 1.4 × 105
αR8A 1 < 1.5 × 10−3 - -
2 < 1.5 × 10−3 - -
αR8K 1 < 1.5 × 10−3 - -
2 < 1.5 × 10−3 - -
αR11A 1 < 1.5 × 10−3 - -
2 < 1.5 × 10−3 - -
αR11K 1 0.08 ± 0.004c - -
2 0.13 ± 0.01 247 ± 41 5.3 × 102
αF39A 1 0.46 ± 0.02 21 ± 3 2.2 × 104
2 0.44 ± 0.02 18 ± 3 2.4 × 104
αF39T 1 2.0 ± 0.1 97 ± 8 2.1 × 104
2 2.0 ± 0.1 44 ± 3 4.5 × 104
βN39A 1 < 1.5 × 10−2 - -
2 < 1.5 × 10−2 - -
αF50A 1 0.19 ± 0.03 280 ± 75 6.8 × 102
2 0.28 ± 0.03 170 ± 33 1.6 × 103
αF50Y 1 9.5 ± 0.5 120 ± 11 7.9 × 104
2 14.9 ± 1.1 118 ± 17 1.3 × 105
a

The steady-state kinetic parameters were determined in 20 mM sodium phosphate buffer (pH 9.0) at 22 °C. Errors are standard deviations.

b

These kinetic parameters were taken from Wang et al. [7].

c

Estimated based on the measured specific activity using 10 mM of 1 (Table 2).

Table 4.

Kinetic Parameters for the Hydration of 6 by CaaD and the Active Site Mutantsa

enzyme kcat (s−1) Km (μM) Kcat/Km (M−1 s−1)
CaaDb 0.7 ± 0.02 110 ± 4 6.4 × 103
αR8A 0.05 ± 0.01 350 ± 90 1.4 × 102
αR8K 0.06 ± 0.005 15 ± 2 4.0 × 103
αR11A <0.01 - -
αR11K 1.7 ± 0.1 1640 ± 140 1.0 × 103
αF39A 0.2 ± 0.01 25 ± 3 8.0 × 103
αF39T 0.3 ± 0.01 11 ± 1 2.7 × 104
βN39A 0.2 ± 0.01 40 ± 6 5.0 × 103
αF50A -c - -
αF50Y 0.7 ± 0.02 45 ± 3 1.6 × 104
a

The steady-state kinetic parameters were determined in 20 mM sodium phosphate buffer (pH 9.0) at 22 °C. Errors are standard deviations.

b

These kinetic parameters were taken from Wang et al. [7].

c

The reaction of αF50A-CaaD with 6 follows a biphasic time course, consisting of an initial burst of acetopyruvate (10) formation followed by a phase that corresponds to steady state formation of 10. The kinetics and mechanism of this reaction are under investigation.

Changing βN39 to an alanine yields an enzyme with very low-level activity using 1 and 2, precluding the accurate determination of kinetic parameters for these reactions. However, this mutation has little effect on the kinetic parameters for the hydratase activity using 6. The kcat for the βN39A-catalyzed reaction is down ~3.5-fold and the Km is down ~2.8-fold, resulting in a nearly comparable kcat/Km to that of wild-type.

In contrast to the large effect of mutations at positions αArg-8 and αArg-11 on the catalytic efficiency of CaaD, the mutation of αPhe-39 to either a threonine or an alanine has less drastic effects on kcat and Km. Using 1, the kcat for the αF39A-catalyzed reaction is down ~8.3 fold and the Km is down ~1.5-fold, resulting in a ~5.5-fold decrease in kcat/Km. For the αF39T mutant, there is a ~1.9-fold decrease in kcat and a ~3.1-fold increase in Km using 1. As a result, the kcat/Km is reduced ~5.7-fold. Using 2, the kcat for the αF39A-catalyzed reaction is down ~11.6-fold and the Km is down ~2-fold, resulting in a ~5.8-fold decrease in kcat/Km. For the αF39T mutant, there is a ~2.5-fold decrease in kcat and a ~1.2-fold increase in Km using 2. As a result, the kcat/Km is reduced ~3.1-fold. Using 6, the kcat for the αF39A-catalyzed reaction is down ~3.5 fold and the Km is down ~4.4-fold, resulting in a nearly comparable kcat/Km to that of wild-type. For the αF39T mutant, there is a ~2.3-fold decrease in kcat and a ~10-fold decrease in Km using 6. As a result, the kcat/Km is increased ~4.2-fold.

Changing αPhe-50 to an alanine has a substantial effect on both kcat and Km. For the αF50A mutant, there is a ~20-fold and a ~18.2-fold decrease in kcat, and a ~9-fold and a ~4.6-fold increase in Km using 1 and 2, respectively. As a result, the kcat/Km is reduced ~176-fold (using 1) or ~87–fold (using 2). Interestingly, the reaction of the αF50A mutant with 6 follows a biphasic time course, consisting of an initial burst of acetopyruvate (10) formation (equal to one equivalent of enzyme) followed by a phase that corresponds to steady state formation of 10 (data not shown). At first glance, this observation could be indicative that product release is the rate-limiting step in the reaction. The kinetics and mechanism of the αF50A-catalyzed hydration of 6 are under investigation.

In contrast to the decreased catalytic activity of the αF50A mutant, changing αPhe-50 to a tyrosine has a positive effect on kcat. For the αF50Y mutant, there are ~2.5-fold and ~2.9-fold increases in kcat, and ~3.9-fold and ~3.2-fold increases in Km, using 1 and 2, respectively. As a result, the kcat/Km is reduced slightly (~1.5-fold using 1 and ~1.1-fold using 2). Using 6, the αF50Y mutation has no effect on kcat and only little effect on Km (~2.4-fold decrease). This results in a ~2.4-fold increase in kcat/Km.

3.4. pH Dependence of the Kinetic Parameters of αF50A

The pH dependences of kcat and kcat/Km for the αF50A-catalyzed hydration of 2 were determined in 20 mM sodium phosphate buffer over the pH range 6.0–9.1 [10]. The pH dependences of kcat and kcat/Km are given by the equations:

kcat(pH)=kcat/(1+[H+]/K1+K2/[H+]) (1)
kcat/Km(pH)=kcat/Km/(1+[H+]/K1+K2/[H+]) (2)

where K1 is the ionization constant of the basic group, K2 is the ionization constant of the acidic group, kcat is the kcat of the enzyme in the single protonated form, and kcat/Km is the kcat/Km of the enzyme in the single protonated form [24,25].

A plot of log kcat/Km versus pH shows a bell-shaped dependence with limiting slopes of unity on either side of the pH maximum, consistent with eq 2, indicating that both a basic group and an acidic group on the enzyme are important for catalysis, where only the single protonated form of the enzyme is active [24]. The substrate (pKa = 4.6) does not titrate in the pH range studied. A fit of the pH-dependence of kcat/Km, which follows the ionization of the free enzyme, to eq (2) gives pKa values for the free enzyme of pK1 = 6.5 ± 0.3 and pK2 = 7.9 ± 0.2 (data not shown). Significantly different values (pK1 = 7.6 ± 0.2 and pK2 = 9.2 ± 0.2) were previously reported for the wild-type enzyme.

At saturating levels of the substrate 2, the pH dependence of kcat shows that the p Ka of the basic group is undetectable, suggesting it has decreased below 6.0. This behavior has also been reported for the wild type CaaD [10], and can be fit by eq (1), but in the present case K1≫[H+] causing the middle term in the denominator to disappear. A fit of the pH-dependence of kcat, which follows the ionization of the enzyme-substrate complex, to the modified eq (1) yields a pK2 value for the enzyme-substrate complex of pKa = 7.9 ± 0.1 (data not shown). This value also differs significantly from that previously reported for the hydratase activity for the wild-type enzyme using 2 (pK2 = 9.5 ± 0.1).

3.5 In silico Docking Experiments Using 2

In order to provide insight into the kinetic results, docking studies were carried out with CaaD using 2. The docking experiment with 2 (Figure 2) is an extension of a previously published docking study [12]. This study suggested that αGlu-52 might play roles in both substrate binding and product release in addition to participating in the chemistry (i.e., activating water for attack). In all crystal structures of CaaD, αGlu-52 is observed in two positions [9,11]. In one position, the carboxylate moiety is rotated out of the active site (PDB entry 3EJ3). In the other position, the carboxylate moiety points directly into the active site (PDB entry 1S0Y). Rotating between these two positions could play a role in product release and, as such, possibly limit the rate of turnover. The results of the docking studies with 2 also show the two positions. The two best predicted scores place the carboxylate moiety (of αGlu-52) out of, or into the active site (Figures 2A and B). In the crystal structures of CaaD, βAsn-39 is within hydrogen bonding distance of αGlu-52. Regardless of the position of αGlu-52 (out of, or into the active site), the carboxylate moiety of αGlu-52 remains within hydrogen bonding distance of the amide moiety of βAsn-39 (dotted lines in Figures 2A and B). The βN39A mutant of CaaD eliminates the interaction, which is consistent with the significantly reduced activity for the trans-3-haloacrylates (even though βAsn-39 is more than 5 Å away from the prolyl nitrogen of Pro-1 and C3 of 2).

Fig. 2.

Fig. 2

The top two poses observed in the docking studies of CaaD with 2 (green stick). A) The “open conformation” pose where the carboxylate group of αGlu-52 points out of the active site and increases the active site volume. B) In a second pose, the carboxylate group of αGlu-52 is positioned to activate a water molecule. In both poses, the carboxylate group is within hydrogen bond distance of βAsn-39 (shown by dotted lines). The open conformation pose has a slightly better docking score than the other pose. The Figure was created with PyMol [20].

Docking studies were also carried out with the individual in silico αR8K and αR11K mutants of CaaD and 2 (Figures 3 and 4). The results provide a possible explanation for the kinetic data collected for the αR8K and αR11K mutants of CaaD. When 2 is docked into the αR8K mutant of CaaD, it is pulled toward the remaining αArg-11 residue (Figure 3), moving the C3 carbon away from the proposed site of water attack (near αGlu-52) by about 1.2 Å. Moreover, the lysyl amino group in the αK8 residue is never observed in a position where it can form an ion-pair or salt bridge with the carboxylate moiety of 2. However, when 2 is docked into the αR11K mutant of CaaD, 2 remains in the same position (within error) as that observed in CaaD (Figure 4). Similar to the results for the αR8K mutant, the docking routines never place the lysyl amino group of the αK11 residue within bonding distance of the carboxylate moiety such that it can form an ion-pair or salt bridge. It appears that the guanidinium moiety of αArg-8 is more important than that of αArg-11 in positioning 2 for the proposed chemistry. The experimental kinetic data agree with the docking results showing that the αR11K mutant maintains 26% relative specific activity while the αR8K mutant yields no detectable activity.

Fig. 3.

Fig. 3

The docking of 2 (blue line) in the in silico αR8K mutant of CaaD. The interaction of the C1 carboxylate group of 2 with αArg-11 is shown in the mutant. This docking pose moves C3 of 2 away from αGlu-52, possibly leading to the observed greatly reduced activity of αR8K mutant (Table 3). For comparison, the docking pose for 2 (green line) in CaaD is shown (from Figure 3B) [12]. The C-3 positions of 2 are shown by the arrows. The Figure was created with PyMol [20].

Fig. 4.

Fig. 4

The docking of 2 (pink line) in the in silico αR11K mutant of CaaD. The binding pose is comparable to that observed for wild type with 2 (green line) (from Figure 3B) [12]. The comparable binding poses might be partially responsible for the observation that the αR11K mutant of CaaD shows activity with 2, although reduced relative to the wild type (Table 3). The C-3 positions of 2 are shown by the arrows. The Figure was prepared using PyMOL [20].

3.6 In silico Docking Experiments Using 6

Docking studies were also carried out with CaaD and 6, as well as two mutants of CaaD (αR11K and αF50A). Docking 6 into the active site of CaaD predicts a similar binding orientation to that observed for 2. However, there are two equivalent predicted binding orientations for 6 (equivalent based on docking scores), both showing five hydrogen bonds to 6: two to each of the active site arginines (αArg-8 and αArg-11) and one to the backbone amide nitrogen of αArg-8 (Figures 5A and B). Both place the C4 of 6 in the same general location as the C3 group of 2 (proximal to αGlu-52). The major difference between the two orientations is the potential hydrogen bonding partners of the C2 carbonyl group of 6. One orientation places the C2 carbonyl group facing the back of the pocket where it can hydrogen bond to the backbone amide of αArg-8 (Figure 5A). The second binding orientation places the C2 carbonyl group facing the front of the pocket with a predicted hydrogen bond to the guanidinium group of αArg-8 (Figure 5B). The residual activity observed for the αR8A and αR8K mutants of CaaD suggests that the first binding orientation might be preferred. Polarization of the unsaturated system through the C2 carbonyl group (drawing electron density away from C4) is thought to be important for the reactivity of 6. In the first orientation, the additional hydrogen bonding interaction is maintained with the backbone amide of the residue at position 8 (Arg, Ala, or Lys).

Fig. 5.

Fig. 5

The two equivalent docking poses for 6 (teal stick) in the active site of CaaD. A) In this pose, five hydrogen bonds are shown between the C1 carboxylate and the C2 carbonyl group of 6 and CaaD: two hydrogen bonds are shown to each of the two arginines (αArg-8 and αArg-11) and one hydrogen bond is shown between the C2 carbonyl group and the backbone amide nitrogen of αArg-8. B) The second pose shows the same hydrogen bonds but the C2 carbonyl group interacts with the guanidinium group of αArg-8. The Figure was prepared using PyMOL [20].

The docking results of 6 with the in silico αR11K mutant of CaaD show no qualitative difference in the location of 6 between wild type and the αR11K mutant. However, the αR11K mutant of CaaD is predicted to have a higher free energy of binding, but not high enough to account for the difference in Km (10-fold increase in Table 4 vs. a predicted 2-fold increase, as calculated by the ΔΔG of binding). Although the Km is probably higher for the αR11K mutant of CaaD, the one reported in Table 4 might be an artifact of non-saturating conditions.

The docking results of 6 with the in silico αF50A mutant of CaaD illustrates the importance of a bulky side chain group in this position to maintain the integrity of the active site pocket. When αPhe-50 is changed to an alanine residue (in silico), the pocket volume increases dramatically and a tunnel forms that leads all the way into the core of the trimer. This extra space is utilized by the docking routine, which attempts to bury and twist 6 into the newly available space (Figure 6). This orientation positions the C4 carbon of 6 a significant distance away from the αGlu-52 residue. (The docking results include orientations comparable to that observed for the wild type, but they have lower docking scores.) The docking results of 2 with the in silico αF50A mutant of CaaD show a similar orientation to that observed for 6 (not shown), which could account for the diminished activity.

Fig. 6.

Fig. 6

Compound 6 (salmon stick) docked in the αF50A mutant of CaaD modeled in silico. The predicted cavities in the mutant are shown in salmon transparent shading. The cavity behind αAla-50 forms a tunnel to the interior of the enzyme. This space is occupied by Phe-50 in the wild-type enzyme. The docking routine twists 6 ~90° from the position shown in Figure 5A, burying C5, C4, and C3 into the newly formed tunnel. The Figure was prepared using PyMOL [20].

4. Discussion

The current working hypothesis for the mechanism of CaaD (Scheme 3) is based on the cumulative results of sequence analysis [1], studies using intermediate analogues as well as reversible and irreversible inhibitors [2,7], site-directed mutagenesis [1,7,9,10], NMR experiments [10], pre-steady-state kinetic analysis [12], and crystallographic studies [9,11]. The importance of βPro-1 and αArg-11 in the hydrolytic dehalogenation of 1 and 2 was initially established by sequence analysis and site-directed mutagenesis [1]. The same study determined that the αR11K mutant partially restores activity and that the αF39A mutant slows the reaction, such that αPhe-39 is not essential for activity [1]. The bulk of the experimental evidence supporting the mechanism came from inhibition as well as NMR and crystallographic studies [7,9,10]. These studies identified the promiscuous hydratase activity of CaaD (i.e., 6 to 10 in Scheme 2A) and the irreversible inhibition of CaaD by 7 and 8 (Scheme 2B) [7]. The results led to the crystal structure of the inactivated CaaD, which identified αArg-8 and αGlu-52 as the two additional players in the mechanism [9]. Subsequent site-directed mutagenesis confirmed their importance. In addition to the position of αGlu-52 in the crystal structure, a hydrogen bond was observed between αGlu-52 and the backbone carbonyl group of βIle-37. This observation indicated that side chain of αGlu-52 is a free acid, which is attributed to the abstraction of a proton from water to produce the inactivating species (either acyl halide or ketene in Scheme 2B). Hence, αGlu-52 is proposed to function as the water-activating base. The NMR studies determined a pKa of 9.3 for βPro-1, suggesting it can be a general acid catalyst and provide a proton at C-2 [10]. Finally, CaaD shows a robust phenylpyruvate tautomerase activity, converting phenylenolpyruvate (11, Scheme 4) to phenylpyruvate (12). This observation is consistent with an enol intermediate (4, Scheme 3 route B) in the reaction, although a halohydrin intermediate cannot be ruled out [2].

Scheme 4.

Scheme 4

The crystal structure of the inactivated CaaD [9] along with a more recent structure of the enzyme in a complex with acetate (from the precipitant buffer) [11] prompted an examination of the roles of βAsn-39, αPhe-39, and αPhe-50 in the dehalogenation mechanism as well as a more extensive analysis of the roles of αArg-8 and αArg-11. βAsn-39, αArg-8, and αArg-11 are absolutely essential for activity (although the αR11K mutant is partially active using 2). αPhe-50 is important for activity, but not as critical as βAsn-39, αArg-8, and αArg-11. αPhe-39 is the least critical residue in this group, as previously reported [1].

The crystal structure of CaaD (where acetate is the ligand) shows a hydrogen bond between the amide side chain of βAsn-39 and the carboxylic acid side chain of αGlu-52 [11]. An overlay of multiple active sites from multiple structures shows the side chain of αGlu-52 in two conformations (out of, and into the active site, Figures 2A and B) [9,11]. However, the hydrogen bond between the side chains of βAsn-39 and αGlu-52 is maintained. These observations prompted the suggestion that βAsn-39 performs a critical role in switching αGlu-52 between conformations where it activates water in one conformation and enables the release of product in the other conformation [11,12]. Switching between conformations could also facilitate the movement of water molecules in and out of the active site for the dehalogenation reaction [11]. The switch between conformations might be the unknown partially rate limiting step, identified by a recent pre-steady state kinetic analysis of the reaction [12].

Like βAsn-39, αArg-8 and αArg-11 are critical for dehalogenation activity. The combined modeling and mutagenesis results provide two new pieces of information. First, the guanidinium group of αArg-8 is more important for activity than that of αArg-11 because it positions C-3 of substrate for attack by water. Docking 2 into the active site of the αR8K mutant moves C3 away from the site of water attack (~1.2 Å) toward the remaining αArg-11 (Figure 3). Second, although the αR11K mutant partially restores activity, the side chain of lysine seems to be too flexible for efficient catalysis. The modeling studies suggest the amino group is not able to interact with the substrate’s C1 carboxylate group in the αR8K or αR11K mutants.

αPhe-50 is important for activity, but not as important as βAsn-39, αArg-8, and αArg-11. This residue likely maintains the structural integrity of the active site, and the loss of the phenyl side chain has significant conseqeunces for activity and the pKa values of active site residues. This might be due to a combination of the newly created space and the breech of the active site wall. It is interesting to note that replacing αPhe-50 with a tyrosine results in a more active dehalogenase, mostly due to the increase in kcat. The basis for the increased activity is not known. αPhe-39 is less important for dehalogenation activity although it along with βIle-37, αLeu-57, and αPhe-50 comprises the halide-binding pocket. Evidently, αPhe-39 is not an important component of this pocket or the pocket is not an important part of the catalytic strategy.

2-Oxo-3-pentynoate (6) has served as a highly informative mechanistic probe of tautomerase superfamily members. It was first synthesized and used as an active-site-directed irreversible inhibitor of 4-oxalocrotonate tautomerase (4-OT) [14,26]. The crystal structure of the inactivated enzyme identified the active site groups involved in inactivation and suggested a mechanism for inactivation as well as the biological reaction [26]. Subsequently, the acetylene compound was used as a probe of the CaaD-catalyzed reaction as well as four additional reactions, those catalyzed by cis-3-chloroacrylic acid dehalogenase (cis-CaaD) [27], malonate semialdehyde decarboxylase (MSAD) [28], and two cis-CaaD homologues, one from Corynebacterium glutamicum designated Cg10062 [29], and one from Mycobacterium smegmatis designated MsCCH2 [30]. cis-CaaD, MASD and Cg10062 convert 6 to 10, whereas MsCCH2 catalyzes a hydration reaction at low pH, but is inactivated at higher pH (vide infra). These different reactions are attributed to the different pKa values of Pro-1. The hydration reaction predominates when Pro-1 is cationic and has a higher pKa (CaaD, cis-CaaD, MSAD, MsCCH2 below its pKa), whereas inactivation is the primary reaction when Pro-1 is neutral due to a lower pKa (4-OT and MsCCH2 above its pKa).

The mechanism for the enzyme-catalyzed conversions of 6 to 10 has not been examined in detail, but has always been thought to involve the Michael addition of water to 6 (Scheme 5) [2730]. In this mechanism for the CaaD-catalyzed reaction, αGlu-52 activates a water molecule for nucleophilic attack at C-4 of 6 while αArg-8 and αArg-11 polarize the carbonyl oxygen and assist in binding of the carboxylate group. Specific roles for αArg-8 and αArg-11 in the mechanism have not been assigned. βPro-1 provides a proton at C-3 to complete the Michael addition of water. (The ketonization of 13 to 10 in Scheme 5 could be an enzyme-catalyzed process or result from a non-enzymatic rearrangement.)

Scheme 5.

Scheme 5

The mutagenesis and modeling results reported here provide further insight into the hydration reaction. Both αArg-11 and αPhe-50 are critical for hydratase activity. In contrast to the dehalogenation reaction, changing βAsn-39 to an alanine has little effect on the hydration reaction. Like the dehalogenation reaction, changing αPhe-39 has little effect on the hydration reaction. Modeling suggests that αArg-11 and Arg-8 are important for binding (via the C1 carboxylate group) and that the backbone amide of αArg-8 is important for polarization of the α,β-unsaturated system (via the C2 carbonyl group). These observations suggest that the positioning of 6 in the active site in the correct (or a fortuituous) orientation for water addition might be more important than activating water or activating the substrate for a reaction.

The behavior of the cis-CaaD homologue designated MsCCH2 with 6 might explain, at least in part, the behavior of the αF50A-catalyzed reaction with 6. Baas et al. reported that incubation of MsCCH2 with 6 results in the formation of 10 as well as the inactivation of the enzyme by covalent modification of Pro-1 [30]. Moreover, the partitioning of 6 between these two processes is pH dependent. At pH 6.5, the enzyme is predominantly a hydratase (reflecting a cationic Pro-1). At pH 8.5, the enzyme is inactivated (reflecting a neutral Pro-1). At pH 7.3–7.5, the enzyme partitions between hydration and inactivation.

The reaction of the αF50A-catalyzed reaction with 6 has not been examined in detail. However, the removal of the side chain of αPhe-50 has serious consequences for the active site, as evidenced by the sharp decrease of the pKa values for both the base and acid catalysts (to 6.5 from 7.6 and 7.9 from 9.2, respectively). The observation that there is a burst of production of 10 followed by its steady state production might involve a partitioning between these two processes, or some other process. Another possibility is that product release is now rate-limiting, as is observed with the CaaD-catalyzed turnover of 2 [12]. The kinetics and mechanism of the α F50A-catalyzed reaction with 6 are under investigation.

Acknowledgments

This research was supported by the National Institutes of Health Grant GM-65324.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Poelarends GJ, Saunier R, Janssen DB. trans-3-Chloroacrylic acid dehalogenase from Pseudomonas pavonaceae 170 shares structural and mechanistic similarities with 4-oxalocrotonate tautomerase. J Bacteriol. 2001;183:4269–4277. doi: 10.1128/JB.183.14.4269-4277.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Poelarends GJ, Johnson WH, Jr, Serrano H, Whitman CP. Phenylpyruvate tautomerase activity of trans-3-chloroacrylic acid dehalogenase: Evidence for an enol intermediate in the dehalogenase reaction. Biochemistry. 2007;46:9596–9604. doi: 10.1021/bi7007189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hartmans S, Jansen MW, Van der Werf MJ, De Bont JAM. Bacterial metabolism of 3-chloroacrylic acid. J Gen Microbiol. 1991;137:2025–2032. doi: 10.1099/00221287-137-8-2025. [DOI] [PubMed] [Google Scholar]
  • 4.van Hylckama Vlieg JE, Janssen DB. Bacterial degradation of 3-chloroacrylic acid and the characterization of cis- and trans-specific dehalogenases. Biodegradation. 1991;2:139–150. doi: 10.1007/BF00124488. [DOI] [PubMed] [Google Scholar]
  • 5.Murzin AG. Structural classification of proteins: new superfamilies. Curr Opin Struct Biol. 1996;6:386–394. doi: 10.1016/s0959-440x(96)80059-5. [DOI] [PubMed] [Google Scholar]
  • 6.Poelarends GJ, Puthan Veetil V, Whitman CP. The chemical versatility of the β-α-β fold: catalytic promiscuity and divergent evolution in the tautomerase superfamily. Cell Mol Life Sci. 2008;65:3606–3618. doi: 10.1007/s00018-008-8285-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang SC, Person MD, Johnson WH, Jr, Whitman CP. Reactions of trans-3-chloroacrylic acid dehalogenase with acetylene substrates: consequences of and evidence for a hydration reaction. Biochemistry. 2003;42:8762–8773. doi: 10.1021/bi034598+. [DOI] [PubMed] [Google Scholar]
  • 8.Baas BJ, Zandvoort E, Geertsema EM, Poelarends GJ. Recent advances in the study of enzyme promiscuity in the tautomerase superfamily. ChemBioChem. 2013;14:917–926. doi: 10.1002/cbic.201300098. [DOI] [PubMed] [Google Scholar]
  • 9.de Jong RM, Brugman W, Poelarends GJ, Whitman CP, Dijkstra BW. The X-ray structure of trans-3-chloroacrylic acid dehalogenase reveals a novel hydration mechanism in the tautomerase superfamily. J Biol Chem. 2004;279:11546–11552. doi: 10.1074/jbc.M311966200. [DOI] [PubMed] [Google Scholar]
  • 10.Azurmendi HF, Wang SC, Massiah MA, Poelarends GJ, Whitman CP, Mildvan AS. The roles of active-site residues in the catalytic mechanism of trans-3-chloroacrylic acid dehalogenase: A kinetic, NMR, and mutational analysis. Biochemistry. 2004;43:4082–4091. doi: 10.1021/bi030241u. [DOI] [PubMed] [Google Scholar]
  • 11.Pegan SD, Serrano H, Whitman CP, Mesecar AD. Structural and mechanistic analysis of trans-3-chloroacrylic acid dehalogenase activity. Acta Crystallogr D Biol Crystallogr. 2008;64:1277–1282. doi: 10.1107/S0907444908034707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Huddleston JP, Schroeder GK, Johnson KA, Whitman CP. A pre-steady-state kinetic analysis of the αY60W mutant of trans-3-chloroacrylic acid dehalogenase: implications for the mechanism of the wild type enzyme. Biochemistry. 2012;51:9420–9435. doi: 10.1021/bi3010686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Burks EA, Yan W, Johnson WH, Jr, Li W, Schroeder GK, Min C, Gerratana B, Zhang Y, Whitman CP. Kinetic, crystallographic, and mechanistic characterization of TomN: elucidation of a function for a 4-oxalocrotonate tautomerase homologue in the tomaymycin biosynthetic pathway. Biochemistry. 2011;35:7600–7611. doi: 10.1021/bi200947w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Johnson WH, Jr, Czerwinski RM, Fitzgerald MC, Whitman CP. Inactivation of 4-oxalocrotonate tautomerase by 2-oxo-3-pentynoate. Biochemistry. 2007;36:15724–15732. doi: 10.1021/bi971608w. [DOI] [PubMed] [Google Scholar]
  • 15.Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2. Cold Spring Harbor Laboratory; Cold Spring Harbor, NY: 1989. [Google Scholar]
  • 16.Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  • 17.Waddell WJ. A simple ultraviolet spectrophotometric method for the determination of protein. J Lab Clin Med. 1956;48:311–314. [PubMed] [Google Scholar]
  • 18.Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989;77:51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
  • 19.Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–461. doi: 10.1002/jcc.21334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.DeLano WL. The PyMol Molecular Graphics System. DeLano Scientific; San Carlos, CA: 2002. [Google Scholar]
  • 21.Seeliger D, Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput-Aided Mol Des. 2010;24:417–422. doi: 10.1007/s10822-010-9352-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hirel PH, Schmitter JM, Dessen P, Fayat G, Blanquet S. Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc Natl Acad Sci USA. 1989;86:8247–8251. doi: 10.1073/pnas.86.21.8247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Czerwinski RM, Johnson WH, Jr, Whitman CP, Harris TK, Abeygunawardana C, Mildvan AS. Kinetic and structural effects of mutations of the catalytic amino-terminal proline in 4-oxalocrotonate tautomerase. Biochemistry. 1997;36:14551–14560. doi: 10.1021/bi971545h. [DOI] [PubMed] [Google Scholar]
  • 24.Cleland WW. Determining the chemical mechanisms of enzyme-catalyzed reactions by kinetic studies. Adv Enzymol Relat Areas Mol Biol. 1977;45:273–387. doi: 10.1002/9780470122907.ch4. [DOI] [PubMed] [Google Scholar]
  • 25.Stivers JT, Abeygunawardana, Mildvan AS, Hajipour G, Whitman CP. 4-Oxalocrotonate tautomerase: pH dependences of catalysis and pKa values of active site residues. Biochemistry. 1996;35:814–823. doi: 10.1021/bi9510789. [DOI] [PubMed] [Google Scholar]
  • 26.Taylor AB, Czerwinski RM, Johnson WH, Jr, Whitman CP, Hackert ML. Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 Å resolution: analysis and implications for the mechanism of inactivation and catalysis. Biochemistry. 1998;37:14692–14700. doi: 10.1021/bi981607j. [DOI] [PubMed] [Google Scholar]
  • 27.Poelarends GJ, Serrano H, Person MD, Johnson WH, Jr, Murzin AG, Whitman CP. Cloning, expression, and characterization of a cis-3-chloroacrylic acid dehalogenase: Insights into the mechanistic, structural, and evolutionary relationship between isomer-specific 3-chloroacrylic acid dehalogenases. Biochemistry. 2004;43:759–772. doi: 10.1021/bi0355948. [DOI] [PubMed] [Google Scholar]
  • 28.Poelarends GJ, Serrano H, Johnson WH, Jr, Hoffman DW, Whitman CP. The hydratase activity of malonate semialdehyde decarboxylase: mechanistic and evolutionary implications. J Am Chem Soc. 2004;126:15658–15659. doi: 10.1021/ja044304n. [DOI] [PubMed] [Google Scholar]
  • 29.Poelarends GJ, Serrano H, Person MD, Johnson WH, Jr, Whitman CP. Characterization of Cg10062 from Corynebacterium glutamicum: Implications for the evolution of cis-3-chloroacrylic acid dehalogenase activity in the tautomerase superfamily. Biochemistry. 2008;47:8139–8147. doi: 10.1021/bi8007388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Baas BJ, Zandvoort E, Wasiel AA, Quax WJ, Poelarends GJ. Characterization of a newly identified mycobacterial tautomerase with promiscuous dehalogenase and hydratase activities reveals a functional link to a recently diverged cis-3-chloroacrylic acid dehalogenase. Biochemistry. 2011;50:2889–2899. doi: 10.1021/bi200071k. [DOI] [PubMed] [Google Scholar]

RESOURCES